Literature DB >> 31985089

A causal framework for classical statistical estimands in failure-time settings with competing events.

Jessica G Young1, Mats J Stensrud2,3, Eric J Tchetgen Tchetgen4, Miguel A Hernán2,5,6.   

Abstract

In failure-time settings, a competing event is any event that makes it impossible for the event of interest to occur. For example, cardiovascular disease death is a competing event for prostate cancer death because an individual cannot die of prostate cancer once he has died of cardiovascular disease. Various statistical estimands have been defined as possible targets of inference in the classical competing risks literature. Many reviews have described these statistical estimands and their estimating procedures with recommendations about their use. However, this previous work has not used a formal framework for characterizing causal effects and their identifying conditions, which makes it difficult to interpret effect estimates and assess recommendations regarding analytic choices. Here we use a counterfactual framework to explicitly define each of these classical estimands. We clarify that, depending on whether competing events are defined as censoring events, contrasts of risks can define a total effect of the treatment on the event of interest or a direct effect of the treatment on the event of interest not mediated by the competing event. In contrast, regardless of whether competing events are defined as censoring events, counterfactual hazard contrasts cannot generally be interpreted as causal effects. We illustrate how identifying assumptions for all of these counterfactual estimands can be represented in causal diagrams, in which competing events are depicted as time-varying covariates. We present an application of these ideas to data from a randomized trial designed to estimate the effect of estrogen therapy on prostate cancer mortality.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal inference; competing risks; g-formula; inverse probability weighting; longitudinal data; survival analysis

Year:  2020        PMID: 31985089      PMCID: PMC7811594          DOI: 10.1002/sim.8471

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  44 in total

1.  Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

Authors:  J M Robins; D M Finkelstein
Journal:  Biometrics       Date:  2000-09       Impact factor: 2.571

2.  A structural approach to selection bias.

Authors:  Miguel A Hernán; Sonia Hernández-Díaz; James M Robins
Journal:  Epidemiology       Date:  2004-09       Impact factor: 4.822

3.  Principal stratification and attribution prohibition: good ideas taken too far.

Authors:  Marshall Joffe
Journal:  Int J Biostat       Date:  2011-09-14       Impact factor: 0.968

4.  An estimator for treatment comparisons among survivors in randomized trials.

Authors:  Douglas Hayden; Donna K Pauler; David Schoenfeld
Journal:  Biometrics       Date:  2005-03       Impact factor: 2.571

5.  Doubly robust estimation in missing data and causal inference models.

Authors:  Heejung Bang; James M Robins
Journal:  Biometrics       Date:  2005-12       Impact factor: 2.571

6.  Sensitivity analyses comparing outcomes only existing in a subset selected post-randomization, conditional on covariates, with application to HIV vaccine trials.

Authors:  Bryan E Shepherd; Peter B Gilbert; Yannis Jemiai; Andrea Rotnitzky
Journal:  Biometrics       Date:  2006-06       Impact factor: 2.571

7.  Semiparametric estimation of the average causal effect of treatment on an outcome measured after a postrandomization event, with missing outcome data.

Authors:  Peter B Gilbert; Yuying Jin
Journal:  Biostatistics       Date:  2009-10-08       Impact factor: 5.899

8.  Concerning the consistency assumption in causal inference.

Authors:  Tyler J VanderWeele
Journal:  Epidemiology       Date:  2009-11       Impact factor: 4.822

9.  Methodologic Issues When Estimating Risks in Pharmacoepidemiology.

Authors:  Jessie K Edwards; Laura L Hester; Mugdha Gokhale; Catherine R Lesko
Journal:  Curr Epidemiol Rep       Date:  2016-09-13

10.  A simple method for principal strata effects when the outcome has been truncated due to death.

Authors:  Yasutaka Chiba; Tyler J VanderWeele
Journal:  Am J Epidemiol       Date:  2011-02-25       Impact factor: 4.897

View more
  31 in total

1.  Effects of intergenerational exposure interventions on adolescent outcomes: An application of inverse probability weighting to longitudinal pre-birth cohort data.

Authors:  Yu-Han Chiu; Sheryl L Rifas-Shiman; Ken Kleinman; Emily Oken; Jessica G Young
Journal:  Paediatr Perinat Epidemiol       Date:  2020-03-12       Impact factor: 3.980

Review 2.  Heterogeneity in design and analysis of ICU delirium randomized trials: a systematic review.

Authors:  Elizabeth Colantuoni; Mounica Koneru; Narjes Akhlaghi; Ximin Li; Mohamed D Hashem; Victor D Dinglas; Karin J Neufeld; Michael O Harhay; Dale M Needham
Journal:  Trials       Date:  2021-05-20       Impact factor: 2.279

3.  Emulating a target trial of statin use and risk of dementia using cohort data.

Authors:  Ellen C Caniglia; L Paloma Rojas-Saunero; Saima Hilal; Silvan Licher; Roger Logan; Bruno Stricker; M Arfan Ikram; Sonja A Swanson
Journal:  Neurology       Date:  2020-08-04       Impact factor: 9.910

4.  Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation.

Authors:  David Merola; Jessica Young; Deborah Schrag; Kueiyu Joshua Lin; Nicholas Robert; Sebastian Schneeweiss
Journal:  Clin Epidemiol       Date:  2022-10-10       Impact factor: 5.814

5.  Propensity Score and Instrumental Variable Techniques in Observational Transplantation Studies: An Overview and Worked Example Relating to Pre-Transplant Cardiac Screening.

Authors:  Ailish Nimmo; Nicholas Latimer; Gabriel C Oniscu; Rommel Ravanan; Dominic M Taylor; James Fotheringham
Journal:  Transpl Int       Date:  2022-06-27       Impact factor: 3.842

6.  Causal inference in the face of competing events.

Authors:  Jacqueline E Rudolph; Catherine R Lesko; Ashley I Naimi
Journal:  Curr Epidemiol Rep       Date:  2020-07-12

7.  Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced CKD and Risk of Adverse Outcomes: A Nationwide Study.

Authors:  Edouard L Fu; Marie Evans; Catherine M Clase; Laurie A Tomlinson; Merel van Diepen; Friedo W Dekker; Juan J Carrero
Journal:  J Am Soc Nephrol       Date:  2020-12-28       Impact factor: 10.121

8.  Probing the Pre-diagnostic Phase of Parkinson's Disease in Population-Based Studies.

Authors:  Lisanne J Dommershuijsen; Agnita J W Boon; M Kamran Ikram
Journal:  Front Neurol       Date:  2021-07-01       Impact factor: 4.003

9.  Estimating the effect of nutritional interventions using observational data: the American Heart Association's 2020 Dietary Goals and mortality.

Authors:  Yu-Han Chiu; Jorge E Chavarro; Barbra A Dickerman; JoAnn E Manson; Kenneth J Mukamal; Kathryn M Rexrode; Eric B Rimm; Miguel A Hernán
Journal:  Am J Clin Nutr       Date:  2021-08-02       Impact factor: 8.472

10.  Causal Inference in Studying the Long-Term Health Effects of Disasters: Challenges and Potential Solutions.

Authors:  Koichiro Shiba; Takuya Kawahara; Jun Aida; Katsunori Kondo; Naoki Kondo; Peter James; Mariana Arcaya; Ichiro Kawachi
Journal:  Am J Epidemiol       Date:  2021-09-01       Impact factor: 5.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.